Rahul Banerjee, MD, FACP

/content/dam/www/faculty-photos/B/rahul-banerjee/rahul-banerjee.jpg
Dr. Rahul Banerjee MD, FACP
Faculty Member

Rahul Banerjee, MD, FACP

Assistant Professor, Clinical Research Division, Fred Hutch

Assistant Professor
Clinical Research Division, Fred Hutch

Dr. Rahul Banerjee is a physician-researcher who specializes in multiple myeloma, a blood cancer caused by plasma cells that can cause bone and kidney damage. Dr. Banerjee also treats patients with AL amyloidosis, a related but rarer condition that is treated similarly through close collaboration between cancer doctors, kidney doctors, and heart doctors. He has a particular research interest in cellular immunotherapies such as CAR T-cell therapies, where the patient's immune cells are genetically modified to recognize and eliminate tumor cells. He is a member of the International Myeloma Working Group and has published over 70 peer-reviewed publications with an emphasis on improving the experiences of patients as they undergo treatment for multiple myeloma.

Other Appointments & Affiliations

Assistant Professor, Division of Hematology and Oncology, University of Washington

Assistant Professor
Division of Hematology and Oncology, University of Washington

Member, Content Committee, American Society for Transplantation and Cellular Therapy (ASTCT)

Member, Content Committee
American Society for Transplantation and Cellular Therapy (ASTCT)

Member, Plasma Cell Disorders Working Committee, Center for International Blood & Marrow Transplant Research (CIBMTR)

Member, Plasma Cell Disorders Working Committee
Center for International Blood & Marrow Transplant Research (CIBMTR)

Member, International Myeloma Working Group

Member
International Myeloma Working Group

Education

Advanced Fellowship, BMT and Cellular Therapy, University of California San Francisco, 2021-2022

Fellowship, Hematology/Oncology University of California San Francisco, 2018-2021

Chief Residency (Quality Improvement), Internal Medicine, Philadelphia VA Medical Center, 2017-2018

Residency, Internal Medicine, Hospital of the University of Pennsylvania, 2014-2017

MD, Alpert Medical School, Brown University, 2010-2014

ScB, Brown University, Providence, RI, (Magna Cum Laude), 2006-2010

Research Interests

Multiple myeloma

Chimeric antigen receptor T-cell therapy (CAR T-cell therapy)

Digital health

Patient-reported outcomes

Clinical Expertise

Multiple myeloma

AL amyloidosis

Chimeric antigen receptor T-cell therapy (CAR T-cell therapy)

Research Bibliography

Rahul Banerjee’s Bibliography